Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Management of High Blood Pressure: The First Iranian High Blood Pressure Guideline (Summary)



Khosravi A1 ; Noohi F2 ; Andalib E3 ; Sadeghiyan S1 ; Peighambari M2 ; Sarrafzadegan N4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Hypertension Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Shaheed Rajaei Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
  3. 3. Cardiac Rehabilitation Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Cardiovascular Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Iranian Heart Journal Published:2013

Abstract

Hypertension (HTN) is a major cause of disability and is known as an independent risk factor for cardiovascular disease (CVD). It is also and recognized as a leading risk factor for death in the world, causing an estimated 7.5 million deaths per year (13% of all deaths).1 The current national picture of Iran suggests a high prevalence of HTN in 17.8% of adults aged 25-64 years and 12.7% in children and adolescents.2,4 According to available data from Iran, awareness, treatment, and control of HTN are generally unsatisfactory. Many studies have estimated the awareness and treatment of HTN in Iranians to be approximately 50% and 35%, respectively, while the control rate of HTN is around 1%.3,4 However, strategies such education of patients, their families, and health professionals as well as the implementation of the national guidelines can increase the awareness and improve control levels among Iranian hypertensives.
Related Docs
View other Related Docs
1. The First Iranian Recommendations on Prevention, Evaluation and Management of High Blood Pressure, ARYA Atherosclerosis (2012)
2. Prevalence, Awareness, Treatment, Control, and Risk Factors of Hypertension Among Adults: A Cross-Sectional Study in Iran, Epidemiology and Health (2018)
3. Prevalence of Hypertension in Iran 1980-2012: A Systematic Review, Journal of Tehran University Heart Center (2016)
4. Knowledge, Treatment, Control, and Risk Factors for Hypertension Among Adults in Southern Iran, International Journal of Hypertension (2015)
5. Prevalence, Awareness, Treatment, and Control of Hypertension in an Isfahan State Institution Sample, Journal of Tehran University Heart Center (2018)
6. Hypertension in Non-Type 2 Diabetes in Isfahan, Iran: Incidence and Risk Factors, International Journal of Hypertension (2017)
7. Prevalence of Pre-Hypertension and Hypertension, Awareness, Treatment, and Control of Hypertension, and Cardiovascular Risk Factors in Postmenopausal Women, ARYA Atherosclerosis (2021)
8. Prevalence of High Blood Pressure in Iranian Adults Based on the 2017 Acc/Aha Guideline, Medical Journal of the Islamic Republic of Iran (2019)
Experts (# of related papers)
View all Related Experts
Nizal Sarrafzadegan (64)
Roya Kelishadi (39)
Other Related Docs
9. Nationwide Survey of Prevalence and Risk Factors of Prehypertension and Hypertension in Iranian Adults, Journal of Hypertension (2008)
10. The Iranian Blood Pressure Measurement Campaign, 2019: Study Protocol and Preliminary Results, Journal of Diabetes and Metabolic Disorders (2023)
11. Incident Hypertension and Its Predictors: The Isfahan Cohort Study, Journal of Hypertension (2014)
12. Is Prehypertension a Risk Factors for Cardiovascular Diseases Among Iranian Women?, Journal of Research in Medical Sciences (2012)
13. Maternal or Paternal History: Which One Plays More Important Role in Developing Hypertension?, ARYA Atherosclerosis (2022)
14. The Impact of Obesity on Hypertension and Diabetes Control Following Healthy Lifestyle Intervention Program in a Developing Country Setting, Journal of Research in Medical Sciences (2011)
15. Determinants of Awareness, Treatment and Control of Hypertension in Isfahan, Central Iran, Archives of Medical Science (2009)
16. Evaluating Factors Associated With Uncontrolled Hypertension: Isfahan Cohort Study, Iran, ARYA Atherosclerosis (2014)
17. Determinants of Uncontrolled Hypertension in an Iranian Population, ARYA Atherosclerosis (2014)
18. Awareness, Treatment and Control of Hypertension, Dyslipidaemia and Diabetes Mellitus in an Iranian Population: The Ihhp Study, Eastern Mediterranean Health Journal (2009)
19. Comparison of Multiple Blood Pressure Frequency Methods With Optimum Blood Pressure Measurement Among Iranian Individuals, Journal of Research in Medical Sciences (2020)
20. Prevalence, Awareness, Treatment and Control of Hypertension in Four Middle East Countries, Journal of Hypertension (2017)
21. Anthropometric Indices Predicting Incident Hypertension in an Iranian Population: The Isfahan Cohort Study, Anatolian Journal of Cardiology (2019)
22. The Prevalence and Correlated Determinants of Hypertension and Type 2 Diabetes:A Large Community-Based Study in Isfahan, Iran, Pakistan Journal of Medical Sciences (2012)
23. The Changes in Cardiovascular Disease Risk Factors After the Implementation of the Package of Essential Non-Communicable Disease Control, Journal of Cardiovascular and Thoracic Research (2024)
24. Explaining the Decline in Coronary Heart Disease Mortality Rate Using Impact Model: Estimation of the Changes in Risk Factors and Treatment Uptake in Iran Between 2007 and 2016, ARYA Atherosclerosis (2023)
25. Developing an Appropriate Model for Self-Care of Hypertensive Patients in Iran, ARYA Atherosclerosis (2013)
26. High Blood Pressure and Associated Cardiovascular Risk Factors in Iran: Isfahan Healthy Heart Programme, Medical Journal of Malaysia (2004)
27. Correlation of Hypertension With Waist Circumference in Iranian Adults, High Blood Pressure and Cardiovascular Prevention (2012)
28. Antihypertensive Drug Prescription Trends in Shahrekord, Iran, Journal of Nephropharmacology (2022)
29. Association Between Uncontrolled Hypertension Status and Quality of Life in Hypertensive Patients, Iranian Heart Journal (2014)
30. Prevalence of Hypertension Among Children Based on the New American Academy of Pediatrics Clinical Practice Guidelines, Iranian Journal of Public Health (2023)
31. A Nationwide Report on Blood Pressure of Children and Adolescents According to Socioeconomic Status: The Caspian-Iv Study, Journal of Research in Medical Sciences (2015)
32. Prevalence of Hypertension and Associated Risk Factors in Isfahan, Islamic Republic of Iran, Eastern Mediterranean Health Journal (1999)
33. First Report on Simplified Diagnostic Criteria for Pre-Hypertension and Hypertension in a National Sample of Adolescents From the Middle East and North Africa: The Caspian-Iii Study, Jornal de Pediatria (2014)
34. Self-Rated Health and Its Determinants in Patients With Hypertension in Isfahan in 2019, BMC Public Health (2024)
35. Update of the Clinical Guideline for Hypertension Diagnosis and Treatment in Iran, Clinical Hypertension (2024)
36. Factors Affecting Uncontrolled Hypertension in an Iranian Population, Iranian Heart Journal (2013)
37. Hypertension Control in Industrial Employees: Findings From Shimsco Study, ARYA Atherosclerosis (2012)
38. Blood Pressure in Children of Hypertensive and Normotensive Parents, Indian Pediatrics (2004)
39. Prevalence, Awareness, Treatment, and Control of Hypertension in Rural and Urban Communities in High-, Middle-, and Low-Income Countries, JAMA (2013)
40. First Nationwide Study of the Prevalence of the Metabolic Syndrome and Optimal Cutoff Points of Waist Circumference in the Middle East: The National Survey of Risk Factors for Noncommunicable Diseases of Iran, Diabetes Care (2009)
41. Obesity and Associated Lifestyle Behaviours in Iran: Findings From the First National Non-Communicable Disease Risk Factor Surveillance Survey, Public Health Nutrition (2008)
42. Epidemiologic Evaluation of Stroke Risk Factors Among Rural-Urban Patients in Isfahan University Hospitals, Iran, Journal of Isfahan Medical School (2012)
43. Prevalence of Metabolic Syndrome and Its Components in the Iranian Adult Population: A Systematic Review and Meta-Analysis, Iranian Red Crescent Medical Journal (2015)
44. Secular Trends in Cardiovascular Mortality in Iran, With Special Reference to Isfahan, Acta Cardiologica (1999)
45. The Impact of a 6-Year Comprehensive Community Trial on the Awareness, Treatment and Control Rates of Hypertension in Iran: Experiences From the Isfahan Healthy Heart Program, BMC Cardiovascular Disorders (2010)
46. Trends of National and Sub-National Burden Attributed to Kidney Dysfunction Risk Factor in Iran: 1990-2019, Frontiers in Endocrinology (2023)
47. Prevalence of Prehypertension and Hypertension in a Nationally Representative Sample of Iranian Children and Adolescents: The Caspian-Iv Study, International Journal of Preventive Medicine (2014)
48. The Metabolic Syndrome in Hypertensive and Normotensive Subjects: The Isfahan Healthy Heart Programme, Annals of the Academy of Medicine Singapore (2005)
49. Cardiovascular Disease Burden in the North Africa and Middle East Region: An Analysis of the Global Burden of Disease Study 1990–2021, BMC Cardiovascular Disorders (2024)
50. Prevalence Study of Clinical Disorders in 6-Year Old Children Across Iranian Provinces: Findings of Iranian National Health Assessment Survey, Journal of Research in Medical Sciences (2012)